COMMUNIQUÉS West-GlobeNewswire

Radius Health Announces Latest 2019 Medicare Part D Coverage for TYMLOS® (abaloparatide) Injection
03/10/2018
TYMLOS is now covered for 64% of Medicare Part D insured lives WALTHAM, Mass., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), a science-driven fully integrated biopharmaceutical company that is [...]
Precipio Launches HemeScreen™, a Disruptive, Proprietary Molecular Test for Hematologic Cancers
03/10/2018
Impacts a $100M annual US laboratory market by reducing testing costs through a simple, screening assay NEW HAVEN, Conn., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: [...]
Results from a large observational study combining the National Early Warning Score (NEWS) with suPAR documents that suPARnostic® improves risk stratification in acute medical patients
03/10/2018
Press Release Birkerød, 3 October 2018 ViroGates A/S (Nasdaq First North Denmark: VIRO), who delivers blood test systems, primarily for emergency departments in hospitals, today announces that data from a study [...]
Biogen to Present Data from its Neurology Pipeline at the 2018 International Congress of Parkinson’s Disease and Movement Disorders (MDS)
03/10/2018
CAMBRIDGE, Mass., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Data to be presented from the BIIB092 program for progressive supranuclear palsy and BIIB054 program for Parkinson’s disease highlight Biogen’s commitment to [...]
Cellular Biomedicine Group Obtained NCI Patent License for Next Generation Neoantigen-Reactive Tumor Infiltrating Lymphocyte (TIL) Technology to Treat Solid Tumors
03/10/2018
SHANGHAI, China and CUPERTINO, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc . (NASDAQ: CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in the development of [...]
ADMA BioCenters Receives FDA Approval for Third Plasma Collection Center
03/10/2018
RAMSEY, N.J. and MARIETTA, Ga., Oct. 03, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical company that develops, manufactures [...]
Myriad Genetics Announces Four Presentations at the 2018 American College of Rheumatology Annual Meeting
03/10/2018
SALT LAKE CITY, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today announced that four studies on Vectra ® will be featured at the American College of [...]
Oasmia Presents Positive Efficacy and Safety Data for Doxophos Vet in Treatment of Naïve Dogs with Lymphoma
03/10/2018
Overall response rate data from the (RXE) Phase II study conducted in the US and Sweden met its primary end points and treatment with Doxophos Vet was generally well tolerated. Oasmia’s assessment is that the positive [...]
Emerald Health Therapeutics Enters Research Agreement with VivaCell Biotechnologies to Evaluate Proprietary Cannabis Products
03/10/2018
Research focused on supporting and validating Emerald’s intellectual property and development of its pipeline of proprietary cannabis products VICTORIA, British Columbia, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Emerald Health [...]
Summit Highlights Phase 3-Ready Precision Antibiotic Ridinilazole at IDWeek 2018
03/10/2018
Summit Therapeutics plc (‘Summit’ or the ’Company’) Summit Highlights Phase 3-Ready Precision Antibiotic Ridinilazole at IDWeek 2018 Ridinilazole in Development to Treat C. difficile Infection and Reduce Recurrent [...]
Aclaris Therapeutics Announces Poster Presentations at 2018 American Society for Dermatologic Surgery Annual Meeting and Fall Clinical Dermatology Conference
03/10/2018
WAYNE, Pa., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company focused on identifying, developing, and commercializing innovative therapies to [...]
Optinose to Highlight Data at Two Upcoming Scientific Meetings
03/10/2018
YARDLEY, Pa., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that data concerning [...]
Neon Therapeutics to Present Data from Ongoing Phase 1b NT-001 Clinical Trial at the European Society for Medical Oncology 2018 Congress
03/10/2018
Company to Host Investor Conference Call and Webcast on October 22, 2018 at 8:00 a.m. ET CAMBRIDGE, Mass., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology [...]
T2 Biosystems Announces Customer Presentations at October Conferences
03/10/2018
IDWeek and World Antimicrobial Resistance Congress to feature presentations on T2Bacteria and T2Candida Panels LEXINGTON, Mass., Oct. 03, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the [...]
Capricor Therapeutics to Present at 2018 Cell & Gene Meeting on the Mesa
03/10/2018
Company will Provide Presentation on Cell and Exosome Therapies and Poster on New Research LA JOLLA, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc . (NASDAQ: CAPR) will provide a presentation at [...]
BeyondSpring to Present Clinical Trial Data at Three Upcoming Scientific Conferences
03/10/2018
NEW YORK, Oct. 03, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a global, clinical-stage biopharmaceutical company focused on the development of innovative cancer therapies, announced today that the Company [...]
Tetra Bio-Pharma Moves PPP001 Closer to Commercial Manufacturing with the Issuance of a Drug Establishment License to Ford’s Pharmacy
03/10/2018
ORLEANS, Ontario, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: TBPMF), in partnership with Ford’s Family Pharmacy and [...]
TRU NIAGEN® PRO to be Featured at the North American Menopause Society (NAMS) Annual Meeting
03/10/2018
Women’s health practitioners now have access to TRU NIAGEN® PRO for aging patients LOS ANGELES, Oct. 03, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today that it will highlight its new TRU NIAGEN [...]
BrainStorm Highlights Translational Data and Presentations Supporting NUROWN® Technology Platform as a Best-In-Class Strategy in ALS
03/10/2018
NurOwn® to be Featured at NEALS and Cell & Gene Meeting on the Mesa Conferences NEW YORK and PETACH TIKVAH, Israel, Oct. 03, 2018 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading [...]

Pages